Applied DNA Sciences Inc (OTCMKTS:APDN) is set to announce its earnings results after the market closes on Thursday, August 10th. Analysts expect the company to announce earnings of ($0.07) per share for the quarter.
Applied DNA Sciences (OTCMKTS:APDN) last issued its earnings results on Thursday, May 11th. The technology company reported ($0.13) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.01. Applied DNA Sciences had a negative net margin of 378.72% and a negative return on equity of 128.10%. The firm had revenue of $0.91 million during the quarter, compared to the consensus estimate of $1.25 million. During the same quarter in the prior year, the firm earned ($0.14) earnings per share. The business’s quarterly revenue was up 59.6% on a year-over-year basis. On average, analysts expect Applied DNA Sciences to post $-0.39 EPS for the current fiscal year and $-0.01 EPS for the next fiscal year.
Shares of Applied DNA Sciences Inc (OTCMKTS APDN) opened at 1.70 on Wednesday. Applied DNA Sciences Inc has a 52 week low of $0.90 and a 52 week high of $3.47. The company’s market cap is $44.80 million. The firm has a 50-day moving average of $1.52 and a 200 day moving average of $1.61.
TRADEMARK VIOLATION NOTICE: “Applied DNA Sciences Inc (APDN) Scheduled to Post Quarterly Earnings on Thursday” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/09/applied-dna-sciences-inc-apdn-scheduled-to-post-quarterly-earnings-on-thursday.html.
A number of analysts have commented on APDN shares. ValuEngine lowered shares of Applied DNA Sciences from a “sell” rating to a “strong sell” rating in a research note on Friday, June 2nd. Maxim Group set a $6.00 price target on shares of Applied DNA Sciences and gave the company a “buy” rating in a research note on Tuesday, June 27th.
About Applied DNA Sciences
Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.
Receive News & Ratings for Applied DNA Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.
